FDD: Ocular Drug Delivery: Leveraging Your Assets from Other Therapeutic Areas

Wednesday, October 17 2012
8:00 am – 10:00 am

Location: MassBio, 300 Technology Square, 8th Floor, Cambridge, MA

Download full program (with abstracts & bios) here.

AGENDA:

There will be a panel discussion following the presentations with the participation of Kevin Bitterman, Principal at Polaris Ventures.

An Evolving Paradigm of Ocular Therapeutic Strategy and Delivery Technology Innovation

  • Dr. Tina Guanting Qiu, Pharmaceutical Consultant Affiliate to Biologics Consulting Groups Inc., Council Member of Biomedical Council & Life Sciences at Gerson Lehman Group, MA

Cross Fertilization: Sustained Delivery and Nanotechnology in Ophthalmology

  • Dr. Paul Ashton, CEO, pSivida Corp., Watertown, MA

Formulation for Target Organ-Specific Delivery: How to Improve a Drug’s Therapeutic Index and Generate IP to Protect the Investment

  • Dr. William K. McVicar, CSO, Inotek Pharmaceuticals, Lexington, MA

The Advantages of Doctor Administered Treatments

  • Dr. Michael Patane, CSO, EyeGate Pharma, Waltham, MA

 

Download full program (with abstracts & bios) here.

Share MassBio

 

 

MassBio Golf Classic

BioProcess

EvaluatePharma